Background and purpose Breast cancer can be a major challenge for affected women.
Knowledge of the physical function, symptoms of cancer-related fatigue, anxiety, and …

There is a lack of validated tools to measure fatigue in patients with inflammatory skin,
neuropsychiatric, and medical disorders. The use of nonvalidated tools may compromise the …

Background Reliable estimates of frequency, severity and associated factors of both fatigue
and cognitive impairment after COVID-19 are needed. Also, it is not clear whether the two …

Objectives To describe self-reported characteristics and symptoms of treatment-seeking
patients with post-COVID-19 syndrome (PCS). To assess the impact of symptoms on health …

Background COVID-19 is known to be associated with increased risks of cognitive and
psychiatric outcomes after the acute phase of disease. We aimed to assess whether these …

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and life-threatening disease with
symptoms of hemolysis and thrombosis. Current therapies for this complement-mediated …

Background Despite the high prevalence and major disability associated with fatigue and
cognitive deficits after SARS-CoV-2 infection, little is known about long-term trajectories of …

Background Ankylosing spondylitis (AS) impacts quality of life. We assessed patient-
reported outcomes (PROs), pain, fatigue, health-related quality of life (HRQoL) and work …

Crovalimab is a novel C5 complement inhibitor that enables rapid and sustained C5
inhibition with subcutaneous, low‐volume self‐administration every 4 weeks. COMMODORE …

Background Long COVID is a major problem affecting patient health, the health service, and
the workforce. To optimise the design of future interventions against COVID-19, and to better …